ATE112676T1 - Einen gleichmässig dispergierten partikulären arzneistoff enthaltender kristalliner zuckeralkohol. - Google Patents

Einen gleichmässig dispergierten partikulären arzneistoff enthaltender kristalliner zuckeralkohol.

Info

Publication number
ATE112676T1
ATE112676T1 AT90312752T AT90312752T ATE112676T1 AT E112676 T1 ATE112676 T1 AT E112676T1 AT 90312752 T AT90312752 T AT 90312752T AT 90312752 T AT90312752 T AT 90312752T AT E112676 T1 ATE112676 T1 AT E112676T1
Authority
AT
Austria
Prior art keywords
sugar alcohol
uniformly dispersed
alcohol containing
crystalline sugar
medicinal substance
Prior art date
Application number
AT90312752T
Other languages
English (en)
Inventor
James Wix Duross
Original Assignee
Ici America Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23751666&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE112676(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ici America Inc filed Critical Ici America Inc
Application granted granted Critical
Publication of ATE112676T1 publication Critical patent/ATE112676T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT90312752T 1989-11-22 1990-11-22 Einen gleichmässig dispergierten partikulären arzneistoff enthaltender kristalliner zuckeralkohol. ATE112676T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/441,131 US5075291A (en) 1989-11-22 1989-11-22 Crystalline sugar alcohol containing uniformly dispersed particulate pharmaceutical compound

Publications (1)

Publication Number Publication Date
ATE112676T1 true ATE112676T1 (de) 1994-10-15

Family

ID=23751666

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90312752T ATE112676T1 (de) 1989-11-22 1990-11-22 Einen gleichmässig dispergierten partikulären arzneistoff enthaltender kristalliner zuckeralkohol.

Country Status (14)

Country Link
US (1) US5075291A (de)
EP (1) EP0435450B1 (de)
JP (1) JP3307925B2 (de)
AT (1) ATE112676T1 (de)
AU (1) AU638074B2 (de)
CA (1) CA2030670C (de)
DE (1) DE69013314T2 (de)
ES (1) ES2065499T3 (de)
FI (1) FI95657C (de)
IE (1) IE904219A1 (de)
NO (1) NO905075L (de)
PT (1) PT95964A (de)
TW (1) TW217386B (de)
ZA (1) ZA909313B (de)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5158789A (en) * 1991-08-09 1992-10-27 Ici Americas Inc. Melt cocrystallized sorbitol/xylitol compositions
US5139795A (en) * 1991-08-09 1992-08-18 Ici Americas Inc. Melt crystallized xylitol
JPH069382A (ja) * 1992-04-17 1994-01-18 Takeda Chem Ind Ltd 安定化された固型製剤およびその製造方法
US5512300A (en) * 1992-09-15 1996-04-30 Warner-Lambert Company Prevention of ibuprofen from forming low melting eutectics with other therapeutic agents in solid dosage forms
CA2128820A1 (en) * 1993-07-27 1995-01-28 Walter G. Gowan, Jr. Rapidly disintegrating pharmaceutical dosage form and process for preparation thereof
US5405623A (en) * 1993-09-22 1995-04-11 Wm. Wrigley Jr. Company Chewing gum compositions and methods for manufacturing same
US5397580A (en) * 1993-10-22 1995-03-14 Wm. Wrigley Jr. Company Continuous gum base manufacture using sequential mixers
US6004589A (en) * 1993-09-24 1999-12-21 Wm. Wrigley Jr. Company Chewing gum base manufacturing process using plurality of filler feed inlet locations
US5419919A (en) * 1993-10-22 1995-05-30 Wm. Wrigley Jr. Company Continuous gum base manufacture using paddle mixing
US5773053A (en) * 1993-09-24 1998-06-30 Wm. Wrigley Jr. Company Chewing gum base manufacturing process using plurality of softening agents inlets
US6086925A (en) * 1993-09-24 2000-07-11 Wm. Wrigley Jr. Company Chewing gum base manufacturing process using plurality of lubricating agents feed inlets
US5549757A (en) * 1994-06-10 1996-08-27 Ingredient Technology Corporation Process for recrystallizing sugar and product thereof
US6586006B2 (en) * 1994-08-04 2003-07-01 Elan Drug Delivery Limited Solid delivery systems for controlled release of molecules incorporated therein and methods of making same
PL319143A1 (en) * 1994-09-13 1997-07-21 Wrigley W M Jun Co Continuous method of making chewing gum from the chewing gum base concentrate
US5545416A (en) * 1994-09-13 1996-08-13 Wm. Wrigley Jr. Company Gum base made with reduced antioxidant and method of preparation
CA2199608C (en) 1994-09-13 2001-10-23 Joo Song Method for continuous gum base manufacturing
JPH10505831A (ja) * 1994-09-15 1998-06-09 ザ、プロクター、エンド、ギャンブル、カンパニー オーラル組成物
US5976581A (en) * 1995-09-12 1999-11-02 Wm. Wrigley Jr. Company Continuous chewing gum manufacturing process using rework gum
US6017565A (en) * 1996-02-21 2000-01-25 Wm. Wrigley Jr. Company Method for automated continuous production of chewing gum
US5827549A (en) * 1996-02-21 1998-10-27 Wm. Wrigley, Jr. Company Process control system for automated continuous production of chewing gum
DE19617487A1 (de) † 1996-05-02 1997-11-06 Merck Patent Gmbh Geschmacksverbesserung von Arzneimittelwirkstoffen
KR20010005831A (ko) 1997-03-31 2001-01-15 이시하라 소이치 멜라닌형성 억제제, 피부 화장품 조성물 및 목욕용제
US5840334A (en) * 1997-08-20 1998-11-24 Fuisz Technologies Ltd. Self-binding shearform compositions
US6123980A (en) * 1997-12-01 2000-09-26 Imperial Sugar Company Preparing granulated sugar blends and products
NZ333474A (en) * 1998-01-02 1999-06-29 Mcneil Ppc Inc A chewable tablet containing ibuprofen, fumaric acid and a non hydrocolloid binder e.g. a wax or a fat
US5948388A (en) * 1998-06-12 1999-09-07 Soft Gel Technologies, Inc. Chewable softgel oral hygiene product
US6358060B2 (en) 1998-09-03 2002-03-19 Jsr Llc Two-stage transmucosal medicine delivery system for symptom relief
US20020098264A1 (en) * 1998-11-27 2002-07-25 Cherukuri Subraman R. Medicated chewing gum delivery system for nicotine
AT407111B (de) * 1998-12-22 2000-12-27 Gergely Dr & Co Zucker- und/oder zuckeralkoholhältiges matrixmaterial und verfahren zu seiner herstellung
AU5483600A (en) * 1999-06-11 2001-01-02 Jean A. Chmielewski Pharmaceutical materials and methods for their preparation and use
US7001892B1 (en) 1999-06-11 2006-02-21 Purdue Research Foundation Pharmaceutical materials and methods for their preparation and use
JP4588818B2 (ja) * 1999-09-16 2010-12-01 日本化学機械製造株式会社 錠剤用賦形剤及び錠剤
US6793934B1 (en) 1999-12-08 2004-09-21 Shire Laboratories, Inc. Solid oral dosage form
US6602912B2 (en) * 2000-06-30 2003-08-05 Dermatrends, Inc. Transdermal administration of phenylpropanolamine
DE10026698A1 (de) 2000-05-30 2001-12-06 Basf Ag Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
WO2004098566A2 (en) * 2003-04-30 2004-11-18 Zicam, Llc Chewable lozenge cold remedy composition and method for making same
US20070092583A1 (en) * 2003-04-30 2007-04-26 Tim Clarot Cold remedy composition comprising zinc salts
US20070059358A1 (en) * 2003-07-02 2007-03-15 Tianjin Tasly Pharmaceutical Co., Ltd., China Matrix adjuvants and the drop pills prepared with them
US8377952B2 (en) 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
AT500101A1 (de) * 2004-02-04 2005-10-15 Tritthart Thomas Verkapselungsprozess
US8216610B2 (en) * 2004-05-28 2012-07-10 Imaginot Pty Ltd. Oral paracetamol formulations
JP2008509207A (ja) * 2004-08-12 2008-03-27 レキット ベンキーザー ヘルスケア （ユーケイ） リミテッド 溶融押出しにより作製するパラセタモール、ｎｓａｉｄ及び糖アルコールを含む顆粒
US20090142401A1 (en) * 2005-06-07 2009-06-04 Leah Elizabeth Appel Multiparticulates comprising low-solubility drugs and carriers that result in rapid drug release
AU2006317530B2 (en) 2005-11-28 2011-09-01 Imaginot Pty Ltd Oral therapeutic compound delivery system
EP1832281A1 (de) * 2006-03-10 2007-09-12 Abbott GmbH & Co. KG Verfahren zur Herstellung einer Feststoffdispersion eines aktiven Wirkstoffes
US8642016B2 (en) 2006-07-21 2014-02-04 Jsrnti, Llc Medicinal delivery system, and related methods
US20100222311A1 (en) * 2007-10-19 2010-09-02 Purdue Research Foundation Solid formulations of crystalline compounds
GB0813709D0 (en) * 2008-07-26 2008-09-03 Univ Dundee Method and product
ES2542238T3 (es) 2009-12-22 2015-08-03 Firmenich S.A. Sistema de administración de principios activos
JP5330320B2 (ja) * 2010-06-09 2013-10-30 日本化学機械製造株式会社 錠剤用賦形剤及び錠剤
DE102010033527A1 (de) 2010-08-05 2012-02-09 Acino Pharma Ag Quetiapin-Tabletten
DE102011115690A1 (de) 2011-10-11 2013-04-11 Acino Pharma Ag Quetiapin enthaltende Formulierungen
US20150080567A1 (en) * 2013-09-04 2015-03-19 Nalas Engineering Services Inc. Method to Produce and Scale-Up Cocrystals and Salts Via Resonant Acoustic Mixing
US9375033B2 (en) 2014-02-14 2016-06-28 R.J. Reynolds Tobacco Company Tobacco-containing gel composition
DE102014104676A1 (de) * 2014-04-02 2015-10-08 Heraeus Medical Gmbh Fosfomycin-Zubereitung, ein Verfahren zur Herstellung der Zubereitung und ein die Zubereitung enthaltendes Polymethylmethacrylat-Knochenzementpulver
CN112999181B (zh) * 2019-12-19 2023-11-14 鲁南制药集团股份有限公司 一种富马酸沃诺拉赞片剂

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3200039A (en) * 1962-05-28 1965-08-10 Pfizer & Co C Non-granulated tablets with 20% sorbitol in a particle size of from about 100mu to about 2000mu
US3341415A (en) * 1964-02-12 1967-09-12 Warner Lambert Pharmaceutical Pharmaceutical tablet excipients of solid particles of a binary solid solution of mannitol with a sugar
US4252794A (en) * 1979-12-20 1981-02-24 Ici Americas Inc. Gamma-sorbitol polymorph
US4870059A (en) * 1985-11-27 1989-09-26 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Dehydration of hydrous matter with anhydrous maltose
JPH0728671B2 (ja) * 1987-08-21 1995-04-05 三菱化学株式会社 チュ−インガムの製造方法
US5017400A (en) * 1988-06-10 1991-05-21 Suomen Xyrofin Oy Non-cariogenic sweetener
US5023092A (en) * 1988-06-16 1991-06-11 Ici Americas Inc. Mannitol having gamma sorbitol polymorph
JPH075624B2 (ja) * 1989-01-31 1995-01-25 東和化成工業株式会社 ラクチトール三水和物結晶及びそれを含有する含蜜結晶並びにそれらの製造方法

Also Published As

Publication number Publication date
CA2030670A1 (en) 1991-05-23
FI95657C (fi) 1996-03-11
DE69013314T2 (de) 1995-02-16
TW217386B (de) 1993-12-11
EP0435450A2 (de) 1991-07-03
FI905781A0 (fi) 1990-11-22
US5075291A (en) 1991-12-24
FI95657B (fi) 1995-11-30
JP3307925B2 (ja) 2002-07-29
AU6676990A (en) 1991-05-30
FI905781A (fi) 1991-05-23
EP0435450A3 (en) 1991-09-04
EP0435450B1 (de) 1994-10-12
JPH03209336A (ja) 1991-09-12
ES2065499T3 (es) 1995-02-16
NO905075D0 (no) 1990-11-22
NO905075L (no) 1991-05-23
DE69013314D1 (de) 1994-11-17
CA2030670C (en) 2000-08-08
ZA909313B (en) 1991-10-30
PT95964A (pt) 1991-10-15
IE904219A1 (en) 1991-05-22
AU638074B2 (en) 1993-06-17

Similar Documents

Publication Publication Date Title
ATE112676T1 (de) Einen gleichmässig dispergierten partikulären arzneistoff enthaltender kristalliner zuckeralkohol.
OA07282A (fr) Composition pharmaceutique lyophilisée contenant de l'interféron procédé pour la préparation et procédé pour sa stabilisation.
PT86819A (pt) Process for the preparation of novel insulin derivatives and of pharmaceutical compositions containing the same
HU908075D0 (en) Process for producing thiazol-acyl-amino derivatives substituted with heterocyclic groupas well as pharmaceutical preparatives containing these compounds as active substances
HUT50339A (en) Process for producing benzoxazole derivatives and pharmaceutical compositions comprising the compounds
FI945476A0 (fi) Hitaasti vapautuvat koostumukset ja menetelmä farmaseuttisten koostumusten valmistamiseksi
RU93045145A (ru) Замещенные производные циклогексана и их применение для лечения заболеваний, содержащее их лекарственное средство
ATE65393T1 (de) Ibupropfen-kristallaggregate enthaltendes arzneimittel.
DK102081A (da) Adjuvans til antibiotikum
PT87301A (pt) Process for the preparation of 1,3-dioxanes by products and of pharmaceutical compounds containing them
HUT39439A (en) Process for producing new thiazolidinedione derivatives and pharmaceutical compositions containing them as active agents
HUT50044A (en) Process for producing pharmaceutical composition comprising megestrol acetate as active ingredient
HU904062D0 (en) Process for producing substituted 3-amino-sydnonimines and pharmaceutical preparations containing these compounds as active substance
HUT47204A (en) Insecticides acaricides containing as active substance 2-(2,2-difluor-cycloprophil)-alkyl-esthers and process for production of the active substances
HUT48638A (en) Process for producing antracyclin derivatives and pharmaceutical compositions containing them as active components